We studied some of the biochemical and immunochemical properties of a major apolipoprotein in isolated pulmonary surfactant from dog and rat lungs. These apolipoproteins were purified by DEAE-cellulose chromatography in buffers containing Triton X-100. Purity of the apolipoproteins was assessed by both fused rocket and crossed immunoelectrophoreses. In addition, the apolipoproteins showed one band with an apparent molecular weight of 72 000-73 000 on SDS-polyacrylamide gel electrophoresis. These proteins are composed of two polypeptide chains of 36 000 daltons. When subjected to isoelectric focusing, the major component of the apolipoprotein had an isoelectric point of about 4.4, with very minor components near 4.6. Even though the apolipoproteins of both species had very similar amino acid compositions, including a relatively high glycine content, no immunologic cross-reactivity was observed. Rocket immunoelectrophoretic analysis of several preparations of dog and rat surfactant using the respective purified apolipoproteins as standards indicated that the apolipoprotein constituted 56.9% +/- 4.6. (S.D., n = 3) and 42.1% +/- 2.1 (S.D., n = 2) of the total protein in dog and rat surfactant, respectively.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0005-2760(81)90257-5DOI Listing

Publication Analysis

Top Keywords

dog rat
12
major apolipoprotein
8
pulmonary surfactant
8
biochemical immunochemical
8
rat surfactant
8
apolipoproteins
5
isolation major
4
apolipoprotein
4
apolipoprotein canine
4
canine murine
4

Similar Publications

A cross-species assessment of in silico prediction methods of steady-state volume of distribution using Simcyp Simulators.

J Pharm Sci

December 2024

Certara UK Ltd., Certara Predictive Technologies Division, 1 Concourse Way, Level 2-Acero, Sheffield, S1 2BJ, United Kingdom. Electronic address:

Predicting steady-state volume of distribution (V) is a key component of pharmacokinetic predictions and often guided using preclinical data. However, when bottom-up prediction from physiologically-based pharmacokinetic (PBPK) models and observed V misalign in preclinical species, or predicted V from different models varies significantly, no consensus exists for selecting models or preclinical species to improve the prediction. Through systematic analysis of V prediction across rat, dog, monkey, and human, using common methods, a practical strategy for predicting human V, with or without integration of preclinical PK information is warranted.

View Article and Find Full Text PDF

Examination of the potential clinical application of 5DEX-0509R, the tumor macrophage-targeting nanomedicine.

Cytokine

December 2024

Cancer Research Unit, Sumitomo Pharma Co Ltd, Osaka, Japan. Electronic address:

Toll-like receptors (TLRs) are crucial for the detection of infections and activation of downstream signaling pathways that lead to the production of pro-inflammatory cytokines and interferons. Because of their strong immunostimulatory activity, TLRs are thought to be a "double-edged sword" for systemic treatment, even in the cancer field. To solve this, we have developed dextran-based TAM targeting activator conjugate (D-TAC) technology which successfully uses tumor-associated macrophages (TAMs) to deliver the TLR7 agonist DSP-0509.

View Article and Find Full Text PDF

Leptospirosis is a neglected zoonotic disease that is endemic in tropical regions, including Ecuador. It is caused by spirochetes of the genus , which can infect humans through animal reservoirs such as rats and dogs, or through contact with contaminated water or soil. In March 2023, public health authorities declared a concerning outbreak of leptospirosis in Durán Cantón, located in the Coastal region of Ecuador.

View Article and Find Full Text PDF

Advanced oral breviscapine sustained-release tablets for improved ischemic stroke treatment.

Biomaterials

May 2025

School of Pharmacy, Key Laboratory of Smart Drug Delivery (Ministry of Education), Fudan University, Shanghai, 201203, China. Electronic address:

This study aimed to address the challenges associated with the low oral bioavailability and the necessity for frequent dosing of breviscapine (BRE), a mainstream drug in the treatment of cardiovascular and cerebrovascular diseases. The poor solubility and permeability of BRE in the gastrointestinal tract were identified as significant barriers to effective drug absorption, thereby impacting therapeutic efficacy and patient compliance. To enhance the gastrointestinal absorption of BRE, particles loaded with BRE were engineered utilizing Cremophor EL (CrEL), an absorption enhancer, in conjunction with mesoporous silica, a biocompatible drug delivery vector, formulating mesoporous silica particles loaded with BRE and CrEL (BRE-CrEL@SiO).

View Article and Find Full Text PDF

Background: Low back pain is a major disorder that causes disability and is strongly associated with intervertebral disc degeneration (IDD). Because of the limitations of contemporary interventions, stem cell transplantation (SCT) has been increasingly used to regenerate degenerative discs. Nevertheless, analyses of high-impact papers in this field are rare.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!